Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: An assessment of seven adult patients with long-term follow-up

British Journal of Dermatology

Volumn 163, Issue 1, 2010, Pages 174-182

  Verneuil, L ^a,b,c   Gouarin, S ^a   Comoz, F ^a   Agbalika, F ^c,d   Creveuil, C ^a   Varna, M ^b,c   Vabret, A ^a   Janin, A ^b,c,d   Leroy, D ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

Epstein Barr virus; hydroa vacciniforme; photodermatosis; ultrastructure

Indexed keywords

IMMEDIATE EARLY PROTEIN BZLF1; VIRUS DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYDROA VACCINIFORME; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KERATINOCYTE; LYMPHOCYTE; MALE; PATHOGENESIS; PHOTOSENSITIVITY; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; SKIN;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HUMANS; HYDROA VACCINIFORME; MALE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77954008230     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09789.x     Document Type: Article

References (36)

1. Iwatsuki K, Satoh M, Yamamoto T et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 2006 142 : 587 595.
2. Iwatsuki K, Xu Z, Takata M et al. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol 1999 140 : 715 721.
3. Au WY, Pang A, Choy C et al. Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients. Blood 2004 104 : 243 249.
4. Fan H, Kim SC, Chima CO et al. Epstein-Barr viral load as a marker of lymphoma in AIDS patients. J Med Virol 2005 75 : 59 69.
5. Gotoh K, Ito Y, Shibata-Watanabe Y et al. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis 2008 46 : 1525 1534.
6. Leroy D, Dompmartin A, Michel M et al. Factors influencing the photo-reproduction of hydroa vacciniforme lesions. Photodermatol Photoimmunol Photomed 1997 13 : 98 102.
7. Brengel-Pesce K, Morand P, Schmuck A et al. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol 2002 66 : 360 369.
8. Gartner BC, Kortmann K, Schafer M et al. No correlation in Epstein-Barr virus reactivation between serological parameters and viral load. J Clin Microbiol 2000 38 : 2458.
9. Oono T, Arata J, Masuda T, Ohtsuki Y. Coexistence of hydroa vacciniforme and malignant lymphoma. Arch Dermatol 1986 122 : 1306 1309.
10. Wu YH, Chen HC, Hsiao PF et al. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Int J Dermatol 2007 46 : 1081 1086.
11. Norval M. The effect of ultraviolet radiation on human viral infections. Photochem Photobiol 2006 82 : 1495 1504.
12. Ichihashi M, Nagai H, Matsunaga K. Sunlight is an important causative factor of recurrent herpes simplex. Cutis 2004 74 : 14 18.
13. Rooney JF, Bryson Y, Mannix ML et al. Prevention of ultraviolet-light- induced herpes labialis by sunscreen. Lancet 1991 338 : 1419 1422.
14. Goade DE, Nofchissey RA, Kusewitt DF et al. Ultraviolet light induces reactivation in a murine model of cutaneous herpes simplex virus-1 infection. Photochem Photobiol 2001 74 : 108 114.
15. Ullrich SE, McIntyre BW, Rivas JM. Suppression of the immune response to alloantigen by factors released from ultraviolet-irradiated keratinocytes. J Immunol 1990 145 : 489 498.
16. Rivas JM, Ullrich SE. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 1992 149 : 3865 3871.
17. Beissert S, Hosoi J, Kuhn R et al. Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice. J Invest Dermatol 1996 107 : 553 557.
18. Averbeck M, Beilharz S, Bauer M et al. In situ profiling and quantification of cytokines released during ultraviolet B-induced inflammation by combining dermal microdialysis and protein microarrays. Exp Dermatol 2006 15 : 447 454.
19. Grewe M, Gyufko K, Krutmann J. Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation. J Invest Dermatol 1995 104 : 3 6.
20. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989 170 : 2081 2095.
21. Vieira P, de Waal-Malefyt R, Dang MN et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 1991 88 : 1172 1176.
22. Aberer W, Schuler G, Stingl G et al. Ultraviolet light depletes surface markers of Langerhans cells. J Invest Dermatol 1981 76 : 202 210.
23. Seite S, Zucchi H, Moyal D et al. Alterations in human epidermal Langerhans cells by ultraviolet radiation: quantitative and morphological study. Br J Dermatol 2003 148 : 291 299.
24. Dumay O, Karam A, Vian L et al. Ultraviolet AI exposure of human skin results in Langerhans cell depletion and reduction of epidermal antigen-presenting cell function: partial protection by a broad-spectrum sunscreen. Br J Dermatol 2001 144 : 1161 1168.
25. Stoebner PE, Poosti R, Djoukelfit K et al. Decreased human epidermal antigen-presenting cell activity after ultraviolet A exposure: dose-response effects and protection by sunscreens. Br J Dermatol 2007 156 : 1315 1320.
26. Hsu DH, de Waal Malefyt R, Fiorentino DF et al. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990 250 : 830 832.
27. Tanner JE, Diaz-Mitoma F, Rooney CM, Alfieri C. Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection. J Infect Dis 1997 176 : 1454 1461.
28. Walling DM, Flaitz CM, Hosein FG. Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia. J Infect Dis 2004 189 : 1656 1663.
29. Feederle R, Kost M, Baumann M et al. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 2000 19 : 3080 3089.
30. Becker J, Leser U, Marschall M et al. Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. Proc Natl Acad Sci USA 1991 88 : 8332 8336.
31. Triantos D, Porter SR, Scully C, Teo CG. Oral hairy leukoplakia: clinicopathologic features, pathogenesis, diagnosis, and clinical significance. Clin Infect Dis 1997 25 : 1392 1396.
32. Greenspan JS, Greenspan D, Lennette ET et al. Replication of Epstein-Barr virus within the epithelial cells of oral 'hairy' leukoplakia, an AIDS-associated lesion. N Engl J Med 1985 313 : 1564 1571.
33. Kimura H, Miyake K, Yamauchi Y et al. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. J Infect Dis 2009 200 : 1078 1087.
34. Palefsky JM, Berline J, Greenspan D, Greenspan JS. Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes. J Gen Virol 2002 83 : 317 321.
35. Walling DM, Etienne W, Ray AJ et al. Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia. J Infect Dis 2004 190 : 387 395.
36. Walling DM, Ray AJ, Nichols JE et al. Epstein-Barr virus infection of Langerhans cell precursors as a mechanism of oral epithelial entry, persistence, and reactivation. J Virol 2007 81 : 7249 7268.